Johannes Fibiger remains a central figure in the history of experimental medicine, primarily for his role in developing early clinical trial methodology. Born in 1867 in Silkeborg, Denmark, he rose to become a professor of anatomical pathology at the University of Copenhagen, where his rigorous, data-driven approach to diphtheria treatment established a foundation for modern medical testing standards.
Academic and Military Background
After completing his education at the University of Copenhagen, Fibiger served in the Royal Danish Army Medical Corps between 1894 and 1897. During this military tenure, he completed his doctoral thesis on the bacteriology of diphtheria, receiving his doctorate in 1895. His career path transitioned toward pathology at the University of Copenhagen, where he eventually served as a professor, director of the Institute of Pathological Anatomy, and, between 1925 and 1926, as the university's rector.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Methodological Contributions to Diphtheria Research
At the Blegdamshospitalet, Fibiger advanced the study of Corynebacterium diphtheriae by identifying distinct nasopharyngeal and cutaneous strains. His 1898 trial regarding diphtheria blood serum is recognized as a pioneering controlled clinical trial. By segregating patients into treated and untreated groups, he utilized a structured methodology that predated many modern analytical techniques, allowing for a comparative assessment of mortality rates.
Cancer Research and the Nobel Prize
In 1907, Fibiger observed tumors in wild rats and hypothesized that the presence of the nematode Gongylonema neoplasticum, which he termed Spiroptera carcinoma, was the causative agent for stomach cancer. By 1913, he reported the experimental induction of cancer in healthy rats through this parasite. This research led to him being awarded the 1926 Nobel Prize in Physiology or Medicine. Subsequent research eventually proved these initial conclusions to be mistaken, identifying the observed tumors as non-cancerous lesions linked to vitamin A deficiency rather than parasitic infection.
Fast facts
- Born: 1867, Silkeborg, Denmark
- Died: 1928, Copenhagen
- Education: University of Copenhagen
- Positions: Rector of the University of Copenhagen (1925-1926)
- Award: Nobel Prize in Physiology or Medicine (1926)
- Award: Commander of the Order of the Dannebrog (1926)
- Award: Doctor honoris causa, University of Paris (1927)
- Burial site: Garnison Cemetery
Questions readers ask
What was Johannes Fibiger's most significant contribution to medical science?
He is highly regarded for his early use of controlled clinical trials during his 1898 research into diphtheria serum.
Why was his Nobel Prize-winning research later contested?
Subsequent independent studies revealed that the tumors Fibiger observed were caused by vitamin A deficiency rather than the roundworms he identified, and that the growths were not cancerous.
Achievements
- Nobel Prize in Physiology or Medicine — 1926
- Held posts at University of Copenhagen
- Educated at University of Copenhagen
- Fields of research: anatomical pathology and microbiology
